GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DanCann Pharma AS (XSAT:DANCAN) » Definitions » Accumulated other comprehensive income (loss)

DanCann Pharma AS (XSAT:DANCAN) Accumulated other comprehensive income (loss) : kr0.00 Mil (As of Sep. 2023)


View and export this data going back to 2020. Start your Free Trial

What is DanCann Pharma AS Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. DanCann Pharma AS's Accumulated other comprehensive income (loss) for the quarter that ended in Sep. 2023 was kr0.00 Mil.

DanCann Pharma AS Accumulated other comprehensive income (loss) Historical Data

The historical data trend for DanCann Pharma AS's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DanCann Pharma AS Accumulated other comprehensive income (loss) Chart

DanCann Pharma AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
Accumulated other comprehensive income (loss)
- - - - -

DanCann Pharma AS Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

DanCann Pharma AS Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

DanCann Pharma AS Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of DanCann Pharma AS's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

DanCann Pharma AS (XSAT:DANCAN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DanCann Pharma AS (XSAT:DANCAN) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
XSAT:ARCEDE XSAT:ACUC OSTO:GABA OSTO:EMPLI ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NBIX NSE:DIVISLAB BOM:500124 VTRS SZSE:000963 XPAR:IPN
Traded in Other Exchanges
DCPXF:USA
Address
Rugvaenget 5, Ansager, DNK, DK-6823
Website
https://www.dancann.com
DanCann Pharma AS is a Danish biopharmaceutical Company powered by cannabinoids. DanCann Pharma is a licensed production and distribution Company. The company is focused on discovering, developing, manufacturing, and commercializing novel cannabinoid therapeutics for a broad range of diseases.

DanCann Pharma AS (XSAT:DANCAN) Headlines

No Headlines